The antisense oligonucleotides market offers growth opportunities across diverse disease indications, with promising ...
In this Teach Me in 10, Dr. Cody Palumbo, a Senior Application Scientist in Technical Design at TriLink BioTechnologies, discusses why gRNA purity matters and how advanced purification solutions can ...
iconPCR is transforming PCR assay development. DOE research that at one point required dozens of plates and long hours at the ...
CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to ...
Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately ...
THX Pharma is entering a new strategic phase focused on regulatory approval, early access, and international commercialization of its medicines. Lyon, France - September 29 ...
A group of RNA veterans is launching a new start-up aimed at getting RNA-interfering (RNAi) molecules into the brain to silence the genes that cause neurodegenerative diseases. Called Aerska, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback